title: Consensus report of the Fifth International Forum for Liver MRI.
abstract: OBJECTIVE
  This article reviews topics discussed during the Fifth International Forum for Liver MRI (with a focus on gadoxetic acid-enhanced MRI), which was held in Munich, Germany, in September 2011.
  
  
  CONCLUSIONS
  Growing evidence shows that gadoxetic acid-enhanced MRI has high sensitivity and specificity for diagnosing liver tumors. Hepatobiliary phase imaging adds new information for the characterization of borderline lesions. However, there is a need to develop standardized criteria for interpretation of gadoxetic acid-enhanced MRI in patients with cirrhosis or other risk factors for hepatocellular carcinoma.
authors.affiliation: University Hospital Basel, Clinic of Radiology and Nuclear Medicine, Basel, Switzerland.
authors.forename: Christoph J
authors.initials: CJ
authors.lastname: Zech
authors.forename: Carlo
authors.initials: C
authors.lastname: Bartolozzi
authors.forename: Paulette
authors.initials: P
authors.lastname: Bioulac-Sage
authors.forename: Pierce K
authors.initials: PK
authors.lastname: Chow
authors.forename: Alejandro
authors.initials: A
authors.lastname: Forner
authors.forename: Luigi
authors.initials: L
authors.lastname: Grazioli
authors.forename: Alexander
authors.initials: A
authors.lastname: Huppertz
authors.forename: Herve
authors.initials: H
authors.lastname: Laumonier
authors.forename: Jeong
authors.initials: J
authors.lastname: Min Lee
authors.forename: Takamichi
authors.initials: T
authors.lastname: Murakami
authors.forename: Jens
authors.initials: J
authors.lastname: Ricke
authors.forename: Claude B
authors.initials: CB
authors.lastname: Sirlin
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000175:diagnosis* / Q000473:pathology; D003287:Contrast Media; D055088:Early Detection of Cancer; D019786:Gadolinium DTPA; D005858:Germany; D006801:Humans; D008113:Liver Neoplasms / Q000175:diagnosis* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D017410:Practice Guidelines as Topic
chemical_list: D003287:Contrast Media; C073590:gadolinium ethoxybenzyl DTPA; D019786:Gadolinium DTPA